PFIZER INC
PFE· NYSE· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- 14.5%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +8.5%
We record prices for the companies we cover; PFE is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 5.71B
- Revenue
- $62.6B
- Free cash flow
- $9.1B
- Owner earnings
- $8.3B
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- –
- Net
- 12.4%
- Free cash flow
- 14.5%
- Owner earnings
- 13.2%
- Stock pay
- 1.3%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- 9.0%
- ROE, 5 yr avg
- 16.3%
Growth (CAGR)
- Revenue, 3 yr
- -12.0%
- Revenue, 5 yr
- 8.5%
- Revenue, 9 yr
- 1.9%
- Diluted EPS, 3 yr
- -37.1%
- Diluted EPS, 5 yr
- -3.6%
- Diluted EPS, 9 yr
- 1.7%
- Free cash flow, 3 yr
- -29.6%
- Free cash flow, 5 yr
- -5.7%
- Free cash flow, 9 yr
- -5.0%
Financial health · FY2025
- Cash and investments
- $10.3B
- Total debt
- $64.6B
- Net debt
- $54.3B
- Debt/Equity
- 0.7x
- Debt/FCF
- 7.1x
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 0.3%
Financials: ten years from the 10-Ks
Revenue
$62.6B
+1.9% a year over 9 years
FY2016FY2025
Margins
12.4%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow$9.1BOwner earnings$8.3B
Free cash flow -5.0% a year
FY2016FY2025
Diluted shares
5.71B
-7.2% over 9 years, net buybacks
FY2016FY2025
Net debt (below zero)
-$54.3B
$54.3B more debt than cash
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $52.8B | $52.5B | $40.8B | $40.9B | $41.7B | $73.6B | $91.8B | $50.9B | $63.6B | $62.6B |
| Revenue growth | – | -0.5% | -22.3% | 0.2% | 1.8% | 76.8% | 24.7% | -44.5% | 25.0% | -1.6% |
| Gross margin | – | – | – | – | – | – | – | – | – | – |
| Operating margin | – | – | – | – | – | – | – | – | – | – |
| Net income | $7.2B | $21.3B | $11.2B | $16.0B | $9.2B | $22.0B | $31.4B | $2.1B | $8.0B | $7.8B |
| Net margin | 13.7% | 40.6% | 27.3% | 39.2% | 22.0% | 29.8% | 34.2% | 4.2% | 12.6% | 12.4% |
| Diluted EPS | $1.17 | $3.52 | $1.87 | $2.82 | $1.63 | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 |
| Return on invested capital? | – | – | – | – | – | – | – | – | – | – |
| Cash | ||||||||||
| Operating cash flow | $16.2B | $16.8B | $15.8B | $12.6B | $14.4B | $32.6B | $29.3B | $8.7B | $12.7B | $11.7B |
| Capital expenditure | $1.8B | $2.0B | $2.0B | $2.0B | $2.2B | $2.7B | $3.2B | $3.9B | $2.9B | $2.6B |
| Free cash flow | $14.4B | $14.8B | $13.8B | $10.5B | $12.2B | $29.9B | $26.0B | $4.8B | $9.8B | $9.1B |
| Stock-based compensation | $691.0M | $840.0M | $923.0M | $687.0M | $755.0M | $1.2B | $872.0M | $525.0M | $877.0M | $799.0M |
| Owner earnings? | $13.7B | $14.0B | $12.9B | $9.9B | $11.4B | $28.7B | $25.2B | $4.3B | $9.0B | $8.3B |
| Free cash flow per share | $2.33 | $2.45 | $2.32 | $1.86 | $2.16 | $5.23 | $4.54 | $0.84 | $1.73 | $1.59 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | $5.0B | $5.0B | $12.2B | $8.9B | $0 | $0 | $2.0B | $0 | $0 | – |
| Diluted shares | 6.16B | 6.06B | 5.98B | 5.67B | 5.63B | 5.71B | 5.73B | 5.71B | 5.70B | 5.71B |
| Share count change? | -1.6% | -1.6% | -1.3% | -5.1% | -0.8% | 1.3% | 0.4% | -0.4% | -0.2% | 0.2% |
| Balance sheet | ||||||||||
| Cash and equivalents | $2.6B | $1.3B | $1.1B | $1.1B | $1.8B | $1.9B | $416.0M | $2.9B | $1.0B | $1.1B |
| Short-term investments | $15.3B | $18.6B | $17.7B | $8.5B | $9.7B | $22.0B | $18.7B | $4.4B | $10.9B | $9.2B |
| Total debt | $41.4B | $43.2B | $40.8B | $51.3B | $39.7B | $37.8B | $35.4B | $71.8B | $63.6B | $64.6B |
| Net debt | $23.6B | $23.2B | $22.0B | $41.7B | $28.2B | $13.9B | $16.3B | $64.5B | $51.7B | $54.3B |
| Shareholders' equity | $59.5B | $71.3B | $63.4B | $63.1B | $63.2B | $77.2B | $95.7B | $89.0B | $88.2B | $86.5B |
Latest filings
| 2026-08-04 | 10-Q | Quarterly report |
| 2026-08-04 | 8-K | Earnings release |
| 2026-05-05 | 10-Q | Quarterly report |
| 2026-05-05 | 8-K | Earnings release |
| 2026-03-12 | DEF 14A | Proxy statement |
| 2026-02-26 | 10-K | Annual report |
| 2026-02-03 | 8-K | Earnings release |
| 2025-11-04 | 10-Q | Quarterly report |
| 2025-11-04 | 8-K | Earnings release |
| 2025-08-05 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
